Skip to main content

SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC

Position in IONS — Ionis Pharmaceuticals Inc

CIK 1638555 Boston, MA

Position in IONS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$62,422,083
-$43,006,754 QoQ
Shares Held
787,263
-43.9% QoQ
Ownership
0.474%
of shares outstanding
% of Portfolio
1.62%
of 13F equity value
Holder Rank
#38
of 513 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority Sole 78% Shared 0% None 22%

Common Shares in IONS Over Time

Shares Held

Position Value (USD)

Derivatives in IONS

reported options exposure · as of Mar 31, 2026
CallValue
$0
CallShares
0
PutValue
$33,790,500
PutShares
450,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC holds $293,644,011 across 5 Biotechnology names. IONS ranks #3 (21.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 IONS
Ionis Pharmaceuticals Inc
This page
787,263 $62,422,083

All Filings in IONS

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $62,422,083 787,263
2026-03-31 $33,790,500 450,000
2026-03-31 $105,428,837 1,404,033
2025-12-31 $23,733,000 300,000
2025-12-31 $115,714,671 1,462,706
2025-09-30 $39,193,122 599,100
2025-09-30 $49,065,000 750,000